<DOC>
	<DOCNO>NCT03056534</DOCNO>
	<brief_summary>R3 Delta Post-Approval Study U.S .</brief_summary>
	<brief_title>R3 Delta Ceramic Acetabular System PAS U.S .</brief_title>
	<detailed_description>Post-Approval Study R3 Biolox Delta Ceramic Acetabular System - US The R3 Ceramic Acetabular System indicate use skeletally mature patient require primary total hip arthroplasty due non-inflammatory arthritis ( degenerative joint disease ) osteoarthritis , avascular necrosis , traumatic arthritis . The expected timeline study total approximately 5 year : 6 month site initiation , 12 month subject enrollment , 3 year last subject enrol reach 3 year follow-up interval .</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patient 1875 year old he/she skeletally mature Patient require primary total hip arthroplasty due noninflammatory degenerative joint disease ( degenerative joint disease ) osteoarthritis , avascular necrosis , traumatic arthritis . Patient meet acceptable preoperative medical clearance free treat cardiac , pulmonary , hematological , etc. , condition would pose excessive operative risk Patient willing able participate require followup visit complete study procedure questionnaires Patient consent participate study sign IRB/EC approve informed consent form Patients insufficient quantity quality bone support ; metabolic bone disease ; osteoporosis Patients neurological muscular condition would place extreme load instability upon hip joint Patients active joint infection chronic systemic infection Obese patient obesity define BMI &gt; 40 Skeletal immaturity Known allergy implant material</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Primary Total Hip Arthroplasty</keyword>
	<keyword>Non-Inflammatory Arthritis</keyword>
	<keyword>Degenerative Joint Disease</keyword>
	<keyword>R3 Delta Ceramic Acetabular Insert</keyword>
</DOC>